MEDSIR, an international company specialized in the strategic design of clinical trials is pleased to announce the appointment of Jyoti Mundra, PhD, as Chief Business Officer.
BARCELONA, Spain, Sept. 22, 2022 /PRNewswire/ -- MEDSIR, an international company specialized in the strategic design of clinical trials is pleased to announce the appointment of Jyoti Mundra, PhD, as Chief Business Officer. In her role, Jyoti will help accelerate the growth of MEDSIR while enhancing MEDSIR’s presence and business in North America. She will be leading global business and marketing team to provide clinical solutions to biopharma companies and build a network with hospitals and institutions. “Jyoti’s scientific background paired with her track record of high sales performance makes her great addition to our team and bolsters our presence in North America,” says María Campos, Chief Executive Officer of the company. “MEDSIR is building the market leading solutions for investigator lead clinical trials and provide strategic clinical solutions to biopharma companies. I am excited about the growth of MEDSIR and expansion in the North American market,” said Jyoti Mundra. About Jyoti Mundra View original content:https://www.prnewswire.com/news-releases/jyoti-mundra-phd-appointed-as-new-chief-business-officer-at-medsir-301630965.html SOURCE MEDSIR |